"We need to get rid of the risk aversion that is in the big pharma DNA. Collaborating with startups can help us create a new culture." Frédéric Collet (President, Novartis France & Chairman, Leem)
Novartis
Dina Katabi - an @MIT expert on Artificial Intelligence in Healthcare - The possibilities of AI in clinical trials.
MIT Sloan Global Programs
“Imagine if you could have a smart WiFi box that sits in a home and collects breathing, heartbeat, movements,…https://t.co/d3diJixTj7